Analyst Ratings for Insmed (INSM)
INSM Rating Summary
INSM Price Target Summary
- Highest: $263.00 (Rothschild Redburn)
- Lowest: $148.00 (Jefferies)
- Average: $203.24
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$203.24 (+45%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 90%
Rating Score: 9.1 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays | Eliana Merle | New Coverage | Overweight (N/A) |
231.00 (N/A) |
159.72 (140.13) |
-12.27% | Details |
| 1/23/2026 | Roth/MKM | Adam Walsh | New Coverage | Buy (N/A) |
212.00 (N/A) |
156.32 (140.13) |
-10.36% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
